Irbesartaani (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Irbesartaani" in Finnish language version.

refsWebsite

Global rank Finnish rank

5nih.gov

4^th place

12^th place

4doi.org

2^nd place

10^th place

3worldcat.org

5^th place

9^th place

1europa.eu

68^th place

51^st place

1sanofi.ca

low place

1drugs.com

399^th place

2,670^th place

1springer.com

274^th place

418^th place

1medicines.org.uk

3,823^rd place

low place

1web.archive.org

1^st place

doi.org

dx.doi.org

S Miura, SS Karnik, K Saku: Angiotensin II type 1 receptor blockers: class effects vs. molecular effects. Journal of the renin-angiotensin-aldosterone system, 2011, 12. vsk, nro 1, s. 1–7. PubMed:20603272. doi:10.1177/1470320310370852. ISSN 1470-3203. Artikkelin verkkoversio.
PD Kennewell et al: Comprehensive medicinal chemistry II, s. 157. Elsevier, 2007. ISBN 9780080450445. doi:10.1016/B0-08-045044-X/00003-1.
X Zhang et al: Management of hypertension using olmesartan alone or in combination. Cardiology and Therapy, 2017, 6. vsk, nro 1, s. 13–32. PubMed:28258390. doi:10.1007/s40119-017-0087-5. ISSN 2193-6544. Artikkelin verkkoversio.
M Fujino et al: A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects. Hypertension research, 2010, 33. vsk, nro 10, s. 1044–1052. PubMed:20668453. doi:10.1038/hr.2010.135. ISSN 0916-9636. Artikkelin verkkoversio.

drugs.com

Irbesartan Drugs.com. Viitattu 3.11.2019.

europa.eu

ema.europa.eu

Aprovel, INN-irbesartan ema.europa.eu. Viitattu 3.11.2019.

medicines.org.uk

Candesartan cilexetil 4 mg tablets - Summary of Product Characteristics (SmPC) - (emc) www.medicines.org.uk. Arkistoitu 3.11.2019. Viitattu 3.11.2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

S Miura, SS Karnik, K Saku: Angiotensin II type 1 receptor blockers: class effects vs. molecular effects. Journal of the renin-angiotensin-aldosterone system, 2011, 12. vsk, nro 1, s. 1–7. PubMed:20603272. doi:10.1177/1470320310370852. ISSN 1470-3203. Artikkelin verkkoversio.
X Zhang et al: Management of hypertension using olmesartan alone or in combination. Cardiology and Therapy, 2017, 6. vsk, nro 1, s. 13–32. PubMed:28258390. doi:10.1007/s40119-017-0087-5. ISSN 2193-6544. Artikkelin verkkoversio.
M Fujino et al: A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects. Hypertension research, 2010, 33. vsk, nro 10, s. 1044–1052. PubMed:20668453. doi:10.1038/hr.2010.135. ISSN 0916-9636. Artikkelin verkkoversio.

ncbi.nlm.nih.gov

S Miura, SS Karnik, K Saku: Angiotensin II type 1 receptor blockers: class effects vs. molecular effects. Journal of the renin-angiotensin-aldosterone system, 2011, 12. vsk, nro 1, s. 1–7. PubMed:20603272. doi:10.1177/1470320310370852. ISSN 1470-3203. Artikkelin verkkoversio.
M Fujino et al: A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects. Hypertension research, 2010, 33. vsk, nro 10, s. 1044–1052. PubMed:20668453. doi:10.1038/hr.2010.135. ISSN 0916-9636. Artikkelin verkkoversio.

sanofi.ca

products.sanofi.ca

Avalide 5.3.2019. sanofi-aventis Canada Inc. Viitattu 3.11.2019.

springer.com

link.springer.com

X Zhang et al: Management of hypertension using olmesartan alone or in combination. Cardiology and Therapy, 2017, 6. vsk, nro 1, s. 13–32. PubMed:28258390. doi:10.1007/s40119-017-0087-5. ISSN 2193-6544. Artikkelin verkkoversio.

web.archive.org

Candesartan cilexetil 4 mg tablets - Summary of Product Characteristics (SmPC) - (emc) www.medicines.org.uk. Arkistoitu 3.11.2019. Viitattu 3.11.2019.

worldcat.org

S Miura, SS Karnik, K Saku: Angiotensin II type 1 receptor blockers: class effects vs. molecular effects. Journal of the renin-angiotensin-aldosterone system, 2011, 12. vsk, nro 1, s. 1–7. PubMed:20603272. doi:10.1177/1470320310370852. ISSN 1470-3203. Artikkelin verkkoversio.
X Zhang et al: Management of hypertension using olmesartan alone or in combination. Cardiology and Therapy, 2017, 6. vsk, nro 1, s. 13–32. PubMed:28258390. doi:10.1007/s40119-017-0087-5. ISSN 2193-6544. Artikkelin verkkoversio.
M Fujino et al: A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects. Hypertension research, 2010, 33. vsk, nro 10, s. 1044–1052. PubMed:20668453. doi:10.1038/hr.2010.135. ISSN 0916-9636. Artikkelin verkkoversio.